Beta-lactamase inhibitors
Details for Australian Patent Application No. 2008321444 (hide)
International Classifications
Event Publications
24 June 2010 PCT application entered the National Phase
PCT publication WO2009/064414 Priority application(s): WO2009/064414
7 October 2010 Assignment before Grant
Protez Pharmaceuticals, Inc. The application has been assigned to Novartis International Pharmaceutical Ltd.
15 September 2011 Assignment before Grant
Novartis International Pharmaceutical Ltd. The application has been assigned to Novartis AG
1 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
Application withdrawn under section 141(1). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
8 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
Application withdrawn under section 141(1). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser